Acompanhe as Notícias da Recifes

A research team at McMaster University has developed a targeted approach to treating inflammatory bowel disease (IBD) using bacteriophages, viruses that infect specific bacteria, to disarm harmful microbes without disrupting the broader gut ecosystem.

Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive forms of brain cancer: resistance to chemotherapy. The study shows that an experimental compound called BA-101 can restore the effective

In experiments in which physicians made decisions about treating hypothetical patients, the physicians tended to trust incorrect advice presented as being generated by artificial intelligence (AI), even after being given the opportunity to notice that patient recovery data contra

Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds promise for treating myeloproliferative neoplasms. A new study from scientists at St. Jude Children's Research Hospital showed that inhibiting menin signi

A bad back led Dr. Dale Block to retire from family medicine in 2019 after nearly four decades of treating patients. O recorte ajuda a contextualizar a pauta dentro de Fitness.

Police in southwest England say they have arrested a 26-year-old man on suspicion of murdering politician Ann Widdecombe. Based on initial inquiries, they were not treating the case as terrorism or politically motivated.

Experts raise alarm as firms aiming to maximise assets and sell for profit become more involved in vital public services‘Financial pandemic’: £1 in every £11 spent on UK public contractors goes to private equityNurseries, vets and shops: the sectors where private equity plays a b

Researchers at Oregon State University have potentially found a new way to treat the most aggressive form of brain cancer, glioblastoma, whose two-year survival rate is less than 30%.

A University of Alberta research team has designed a promising alternative for treating antimicrobial-resistant infections, a pressing global health issue. In a paper recently published in Cell Biomaterials, the team describes preclinical testing results for its human-derived pep

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb), is the world's deadliest single-agent infection, responsible for 1.23 million deaths in 2024, according to the World Health Organization. The bacterium's unique outer cell membrane is notoriously hard to pene